Categorynews

Latin America Western Blotting Market 2019-2027 – ResearchAndMarkets.com

August 29, 2019 Off By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Latin America Western Blotting Market 2019-2027” report has been added to ResearchAndMarkets.com’s offering.

Latin America’s western blotting market is expected to proliferate with a CAGR of 5.55% in the forecast duration from 2019-2027.

Brazil, Mexico and countries in rest of Latin America together form the market for western blotting in the Latin American region. Western blotting has found applications in a wide range of areas such as disease diagnosis; biomedical & biochemical research; food & beverage; agriculture; and QC tests in the pharmaceutical, biopharmaceutical and biotechnology industries. The usage of western blot techniques is increasing rapidly due to the prevalence of diseases which are increasing at a rapid rate worldwide.

Stability was witnessed in the overall rate of new HIV infections in Latin America from 2010-2015. However, this stability conceals the differences between children and adults in the region. The major proportion of funding for HIV for the Latin American region comes from domestic sources that demonstrates the Government of Latin America’s commitment to the HIV response.

The U.S. Agency for International Development’s (USAID’s) HIV/AIDS programs have been implemented in the Latin American region. Use of western blotting for HIV testing is expected to increase in this region owing to the implementation of this program.

Key Topics Covered:

1. Latin America Western Blotting Market – Summary

2. Industry Outlook

2.1. Market Definition

2.2. Key Insights

2.2.1. Growing Number of Applications For Western Blotting

2.2.2. Growing Acceptance of Digital Western Blotting

2.3. Porter’s Five Force Analysis

2.4. Market Attractiveness Index

2.5. Vendor Scorecard

2.6. Market Drivers

2.6.1. Growing Occurrence of Hiv And Lyme Disease

2.6.2. High Demand For Proteomics

2.6.3. Rise in Applications For Western Blotting

2.7. Market Restraints

2.7.1. Advancements in Substitute Technologies

2.8. Market Opportunities

2.8.1. Industrialization of Western Blot Instruments

2.9. Market Challenges

2.9.1. Inflated Cost of Antibodies

2.9.2. Growing Research Initiatives And R&D Expenditure By Pharmaceutical And Biotechnology Companies

3. Western Blotting Market Outlook – By Product

3.1. Consumables

3.1.1. Reagents And Buffers

3.1.2. Kits

3.1.3. Other Consumables

3.2. Instruments

3.2.1. Gel Electrophoresis Instruments

3.2.2. Blotting Systems

3.2.2.1. Dry Blotting Systems

3.2.2.2. Semi-Dry Blotting Systems

3.2.2.3. Wet Blotting Systems

3.2.3. Imagers

3.2.3.1. Chemiluminescent Imagers

3.2.3.2. Fluorescent Imagers

3.2.3.3. Other Imagers

4. Western Blotting Market Outlook – By Application

4.1. Biomedical & Biochemical Research

4.2. Disease Diagnostics

4.3. Agriculture

4.4. Other Applications

5. Western Blotting Market Outlook – By End-User

5.1. Research Institutes

5.2. Pharmaceutical & Biotechnology Companies

5.3. Diagnostic Centers

5.4. Other End-Users

6. Western Blotting Market – Regional Outlook

6.1. Latin America

6.1.1. Brazil

6.1.2. Mexico

6.1.3. Rest of Latin America

7. Competitive Landscape

7.1. F. Hoffman La-Roche Ltd.

7.2. Merck Kgaa

7.3. Thermo Fisher Scientific, Inc.

7.4. Bio-Rad Technologies Inc.

7.5. Bio-Techne Corporation

7.6. Cell Signaling Technology Inc.

7.7. Ge Healthcare

7.8. Li-Cor, Inc.

7.9. Advansta

7.10. Azure Biosystems, Inc.

7.11. Perkinelemer, Inc.

7.12. Roche Diagnostics International, Inc.

7.13. Roche Diagnostics

7.14. Lumigen, Inc.

7.15. Rockland Immunochemicals, Inc.